An Evaluation of the Impact of REMS on Spontaneous Reporting for Marketed Products

被引：0
|
作者：
Jain, Reema [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
431
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [41] REVIEW OF MARKETED MEDICINAL PRODUCTS - INTERNATIONAL IMPLICATIONS
    TUCK, GC
    AGENTS AND ACTIONS, 1978, 8 (04): : 424 - 426
  • [42] Food allergens in skincare products marketed for children
    Adomaite, Ieva
    Vitkuviene, Angele
    Petraitiene, Sigita
    Rudzeviciene, Odilija
    CONTACT DERMATITIS, 2020, 83 (04) : 271 - 276
  • [43] Evaluation of cardiac adverse events with ponatinib using a spontaneous reporting database
    Kanbayashi, Yuko
    Uchida, Mayako
    Nakano, Kana
    Wakabayashi, Haruka
    Shimizu, Tadashi
    ONCOLOGY, 2023, 101 (06) : 397 - 405
  • [44] Draft guidance on reports for marketed products in Canada
    Reactions Weekly, 2016, 1591 (1) : 2 - 2
  • [45] Study of ginsenosides in ginseng products marketed in Portugal
    Farinha, A
    Cepeda, AM
    Martins, JM
    Moreira, AP
    NATURAL PRODUCTS IN THE NEW MILLENNIUM: PROSPECTS AND INDUSTRIAL APPLICATION, 2002, 47 : 81 - 89
  • [46] Commercially bioavailable proprietary technologies and their marketed products
    Alam, Mohd Aftab
    Al-Jenoobi, Fahad I.
    Al-mohizea, Abdullah M.
    DRUG DISCOVERY TODAY, 2013, 18 (19-20) : 936 - 949
  • [47] Clinical evaluation of marketed orthodontic products: are researchers behind the times? A meta-epidemiological study
    Seehra, Jadbinder
    Pandis, Nikolaos
    Fleming, Padhraig S.
    PROGRESS IN ORTHODONTICS, 2017, 18
  • [48] Potassium bromide products marketed for use in dogs
    Kornheiser, Kenneth M.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2012, 240 (09): : 1056 - 1056
  • [49] Adverse Drug Reaction of Lomefloxacin with the Marketed Products
    Garg, R.
    Agrawal, M.
    Mishra, C. K.
    Gupta, R. N.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (02) : 228 - 228
  • [50] Reporting of serious and unexpected spontaneous cases of marketed drug: Does the ICH and regulatory authorities need to re-assess the guidelines and recommendations?
    Agrawal, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (08) : 821 - 821
12345